Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EWTX Edgewise Therapeutics, Inc.

休市中 12-27 16:00:00 EST

28.74

-0.92

-3.10%

盘后28.84

+0.10+0.35%

19:41 EST

最高29.86	最低28.37	成交量56.14万
今开29.46	昨收29.66	日振幅5.02%
总市值27.21亿	流通市值16.91亿	总股本9,469万
成交额1,616万	换手率0.95%	流通股本5,885万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EWTX","market":"US","secType":"STK","nameCN":"Edgewise Therapeutics, Inc.","latestPrice":28.74,"timestamp":1735333200000,"preClose":29.66,"halted":0,"volume":561437,"hourTrading":{"tag":"盘后","latestPrice":28.8399,"preClose":28.74,"latestTime":"19:41 EST","volume":17726,"amount":509533.36,"timestamp":1735346516372},"delay":0,"floatShares":58845646,"shares":94688517,"eps":-1.463546,"marketStatus":"休市中","change":-0.92,"latestTime":"12-27 16:00:00 EST","open":29.46,"high":29.86,"low":28.37,"amount":16161355.928026,"amplitude":0.050236,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.463546,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":29.66,"preHourTrading":{"tag":"盘前","latestPrice":29.66,"preClose":29.66,"latestTime":"09:18 EST","volume":11616,"amount":344531.37312,"timestamp":1735309090182},"postHourTrading":{"tag":"盘后","latestPrice":28.8399,"preClose":28.74,"latestTime":"19:41 EST","volume":17726,"amount":509533.36,"timestamp":1735346516372},"volumeRatio":0.772753999459124,"impliedVol":0.9337,"impliedVolPercentile":0.5278},"requestUrl":"/m/hq/s/EWTX/tweets","defaultTab":"tweets","newsList":[{"id":"2491361349","title":"BUZZ--美国股票走势-HeartBeam、泰瑞达、Keysight Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2491361349","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491361349?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:47","pubTimestamp":1734364027,"startTime":"0","endTime":"0","summary":"** Checkpoint Therapeutics   ： BUZZ - 该公司的皮肤癌药物获得美国食品和药物管理局批准后上涨。** LeMaitre Vascular   ： BUZZ - 计划发行可转换债券的业绩下滑   ** 菲利普斯66  : BUZZ - 将以8.65亿美元出售德克萨斯州管道股份，股价下跌   ** Keysight Technologies   : BUZZ - 在摩根大通将股票评级提升至 \"增持 \"后上涨   ** 巴里克黄金  : BUZZ - 称将在黄金运输受阻的情况下暂停马里业务   ** 钢铁动力  : BUZZ - 因第四季度利润预期低于预期而下跌   ** Microchip Technology   : BUZZ - 下跌，因BofA将其评级下调至 \"跑输大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCHP","EWTX","LEV","BEAT","CLPR","VRDN","CMG","KEYS","TQQQ","F","DOG","QID","XOM","NTAP","TSYW.SI","PSX","QLD","MAS","BHVN",".IXIC","NVIW.SI","HON","STLD","DDM","NQmain","MNQmain","PLBY",".SPX","LMAT","SQQQ","USJW.SI","ALK","CPRI","PSQ","PEPG","ADGM",".DJI","UDOW","CKPT","TER","CBRE"],"gpt_icon":1},{"id":"2491914926","title":"BUZZ--美国股票走势-诺和诺德、特斯拉、微策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2491914926","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491914926?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:15","pubTimestamp":1734358514,"startTime":"0","endTime":"0","summary":"nL4N3NH0QL  ** Checkpoint Therapeutics Inc CKPT.O:BUZZ--该公司的皮肤癌药物获得美国食品和药物管理局批准后股价上涨。nL4N3NH0QI  ** NetApp NTAP.O:BUZZ - JPM将其评级上调至 \"增持\"，原因是人工智能引领的增长将改善IT预算。nL4N3NH0R7  ** 霍尼韦尔国际HON.O:BUZZ - 公司称考虑分拆航空业务，股价上涨。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4T3NH10L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","CKPT","LU0011850046.USD","LU0496365809.HKD","LU1861558580.USD","LU0971096721.USD","LU0211327993.USD","IE00BDCRKT87.USD","PLBY","BK4555","LU2552382215.SGD","LU0976567544.SGD","LU1670627923.USD","CPRI","FBIO","TSLA","BK4533","VRDN","CTLT","LU1894683348.USD","LU1917777945.USD","MAS","MSTR","F","BK4534","LU1145028129.USD","LU1084165304.USD","NTAP","BK4146","LU0980610538.SGD","TSYW.SI","LU2237443465.HKD","CBRE","BHVN","LU1244550221.USD","BK4524","LU0070302665.USD","BK4596","LU1496350171.SGD","LU0234572021.USD","LU0053671581.USD","LU1670628061.USD","IE0034235188.USD","NKE","LU0417517546.SGD","LU0130102774.USD","HON"],"gpt_icon":1},{"id":"2491667185","title":"BUZZ--美国股票走势-NetApp、霍尼韦尔、世邦魏理仕集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2491667185","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491667185?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:14","pubTimestamp":1734351295,"startTime":"0","endTime":"0","summary":"nL4N3NH0QL  ** Checkpoint Therapeutics CKPT.O：BUZZ--该公司的皮肤癌药物获得美国食品和药物管理局批准后股价上涨。nL4N3NH0R7  ** 霍尼韦尔国际HON.O:BUZZ - 公司称考虑分拆航空业务，股价上涨。nL4N3NH0Q5  ** Edgewise Therapeutics EWTX.O:BUZZ - 因遗传疾病药物达到中期研究目标而上涨 nL4N3NH0SQ  ** 世邦魏理仕集团CBRE.N:BUZZ - 在摩根大通将其评级上调至 \"增持 \"后上涨 nL4N3NH0TA (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4T3NH0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4596","LU1620156130.USD","LU1721427968.SGD","CPRI","IE00BFXG1179.USD","EWTX","NTAP","IE00BZ1G4Q59.USD","LU0154245756.USD","LU2023250330.USD","IE00B1BXHZ80.USD","BK4079","FBIO","LU0267386448.USD","LU2413665964.HKD","LU1244550577.SGD","HON","BK4504","CBRE","LU1668664300.SGD","LU1894683348.USD","TSLA","BK4207","IE00BK4W5M84.HKD","BK4574","LU0820561909.HKD","LU1267930490.SGD","MSTR","LU1670627923.USD","LU0823414478.USD","LU0980610538.SGD","LU0689472784.USD","IE00BK4W5L77.USD","LU0348723411.USD","IE00B3S45H60.SGD","SG9999002224.SGD","MAS","LU0234570918.USD","SG9999015986.USD","BK4566","TSYW.SI","CKPT","CTLT","LU2413666004.HKD","LU0316494557.USD","LU0211326755.USD","LU1670628061.USD"],"gpt_icon":1},{"id":"2491866485","title":"BUZZ-遗传性疾病药物达到中期研究目标，Edgewise Therapeutics 受益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2491866485","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491866485?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:41","pubTimestamp":1734349303,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    12月16日 - ** Edgewise Therapeutics 公司股价在盘前交易中上涨约 17% 至 32.28 美元 ** 公司称其试验性遗传疾病药物在一项中期研究中达到了主要目标** 该药物名为sevasemten，正在开发用于治疗贝克尔肌肉萎缩症，这是一种导致进行性肌肉无力和退化的罕见疾病。 ** Sevasemten 有助于显著降低肌酸激酶的水平，肌酸激酶是一种与研究中骨骼肌损伤有关的酶--EWTX** 截至上一交易日收盘，该公司股价在年初翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LENZ","EWTX","BK4539"],"gpt_icon":0},{"id":"2486827077","title":"Edgewise Therapeutics, Inc.盘中异动 早盘股价大涨5.80%报33.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827077?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:31","pubTimestamp":1732717860,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时31分，Edgewise Therapeutics, Inc.股票出现异动，股价大幅拉升5.80%。截至发稿，该股报33.94美元/股，成交量1447股，换手率0.00%，振幅0.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为784.53%、23.12%、6.72%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Elevai Labs, Inc.、Oragenics Inc.，振幅分别为13.97%、8.20%、6.38%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223100971a8dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223100971a8dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","BK4139","EWTX"],"gpt_icon":0},{"id":"2483218306","title":"Edgewise Therapeutics, Inc.2024财年第三财季实现净利润-34.13百万美元，同比减少32.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483218306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483218306?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Edgewise Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-34.13百万美元，同比减少32.75%；其中营业收入为0.00美元，每股基本收益为-0.36美元。从资产负债表来看，Edgewise Therapeutics, Inc.总负债22.41百万美元，其中短期债务992000.00美元，资产负债比为0.23，流动比率为0.27。机构评级：截至2024年11月16日，当前有6家机构对Edgewise Therapeutics, Inc.目标价做出预测，其中目标均价为43.17美元，其中最低目标价为33.00美元，最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316a23b89cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316a23b89cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2483513358","title":"Edgewise Therapeutics, Inc.盘中异动 下午盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483513358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483513358?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:38","pubTimestamp":1731526720,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时38分，Edgewise Therapeutics, Inc.股票出现异动，股价快速下跌5.06%。截至发稿，该股报33.42美元/股，成交量32.2608万股，换手率0.34%，振幅6.39%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为619.13%、553.18%、161.95%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为139.00%、86.83%、73.71%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033841a234ea0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033841a234ea0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","EWTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2483082300","title":"美国研究综述-AMN 医疗保健服务公司、Chart Industries 公司、家得宝公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2483082300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483082300?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:30","pubTimestamp":1731497406,"startTime":"0","endTime":"0","summary":"    路透11月13日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 AMN 医疗保健服务公司、Chart Industries 公司和家得宝公司。* 908 Devices Inc   ：Leerink Partners将目标价从12美元下调至4美元             * 908 Devices Inc   ：Leerink Partners 将其目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOX","IRON","AMN","CSX","ACLX","DAY","COLD","HCSG","BHVN","ALIT","CHGG","LU2133065610.SGD","AISP","EWTX","DCOM","BBIO","DOCS","COGT","BMY","APA","ABBV","BCAX","MASS","HD","GTLS","CHH","AESI","CHRW","LU2106854487.HKD","LU0128525689.USD","BLFS","BK4566","CRNX","BK4567","CLF","CCCS","BK4505","LU2249611893.SGD","CAVA","BK4534","SATS","ALB","FDX","LU0256863902.USD","BLTE","LU2065731478.USD","ARCH","ATLC","COTY","AXSM"],"gpt_icon":0},{"id":"2481587130","title":"Edgewise Therapeutics, Inc.盘中异动 下午盘大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481587130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481587130?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:47","pubTimestamp":1731005250,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时47分，Edgewise Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。截至发稿，该股报34.78美元/股，成交量39.4834万股，换手率0.42%，振幅5.68%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为935.26%、495.75%、119.36%，振幅较大的相关个股有Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为258.62%、193.53%、72.18%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802473098e41453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802473098e41453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EWTX","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2474059637","title":"美国研究综述-ANI Pharmaceuticals、Deere & Co、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2474059637","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474059637?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:47","pubTimestamp":1728632832,"startTime":"0","endTime":"0","summary":"    路透10月11日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 ANI 制药公司、迪尔公司和 Zoetis 公司。要闻 * ANI 制药公司   ：Piper Sandler给予该公司增持评级 * 迪尔公司   ：摩根大通将目标价从 360 美元上调至 420 美元 * Zoetis Inc   ：摩根大通将目标价从22美元上调至230美元 以下是路透周五报道的美国公司研究行动摘要。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1868837136.USD","IE00BLSP4452.SGD","BK4539","CE","ANIP","LU0158827948.USD","DPZ","LU0097036916.USD","ISRG","LU1244550494.USD","DE","LU1119994496.HKD","LU1983299246.USD","DAL","LU1804176565.USD","HUN","LU0158827781.USD","LU0417517546.SGD","LU0289739343.SGD","LU0690374961.EUR","WLK","ARHS","BK4152","BK4500","LU2264538146.SGD","LU0128525689.USD","BK4082","LU0211326839.USD","LU1989764664.SGD","NAPA","LU2271345857.HKD","SGXZ23171101.USD","XNCR","FLUT","LU0061475181.USD","LU0208291251.USD","EMN","LU0310799852.SGD","LU1989763690.USD","ZTS","IDXX","LU0971096721.USD","LU1989763427.SGD","BK4524","EWTX","CC","LU0256863811.USD"],"gpt_icon":1},{"id":"2474229730","title":"Edgewise Therapeutics, Inc.盘中异动 早盘快速上涨5.05%报29.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474229730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474229730?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:17","pubTimestamp":1728483437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时17分，Edgewise Therapeutics, Inc.股票出现异动，股价快速上涨5.05%。截至发稿，该股报29.93美元/股，成交量24.3058万股，换手率0.26%，振幅4.46%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为662.30%、316.69%、153.55%，振幅较大的相关个股有Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为42.02%、39.02%、19.67%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009221718a1df6d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009221718a1df6d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2470448272","title":"Edgewise Therapeutics, Inc.盘中异动 快速下跌5.02%报25.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470448272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470448272?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:12","pubTimestamp":1727201539,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时12分，Edgewise Therapeutics, Inc.股票出现波动，股价急速下挫5.02%。截至发稿，该股报25.16美元/股，成交量42.8638万股，换手率0.46%，振幅5.83%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4528.64%、198.00%、176.35%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为122.95%、58.52%、45.08%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502121998e38b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502121998e38b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","EWTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2468917646","title":"美国研究综述-Factset、联邦快递、赛默飞世尔科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468917646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468917646?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:20","pubTimestamp":1726816830,"startTime":"0","endTime":"0","summary":"    路透9月20日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Factset、联邦快递和赛默飞世尔科技。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH","EWTX","PBF","IDA","MEDP","LU0114720955.EUR","PNW","LU2065170008.USD","DNA","ASMB","FDX","LU2210149790.SGD","DK","FDS","GLW","LU2210150020.SGD","OGE","PARR","BK4519","ENVA","DRI","LU0957791311.USD","BK4504","TMO","CRL","LU1670628061.USD","IQV","LU0342679015.USD","LU1854103824.USD","IE00B3T34201.USD","ALL","LU2095319765.USD","AJG","PSTL","DINO","IE0009355771.USD","IE00BMG7P702.HKD","AEP","MPC","PSX","DUK","EXC","EVRG","GIS","IE00BVYPNV92.GBP","LNT","AEE","D","LU2063271972.USD","IE00B19Z8X17.USD"],"gpt_icon":1},{"id":"2468042765","title":"BUZZ--美国股票走势-Spotify、Coursera、Tandem 糖尿病护理公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468042765","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468042765?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:05","pubTimestamp":1726761931,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月19日 - 在美联储以削减半个百分点开启宽松周期并预测将有更多削减后，华尔街周四反弹，标普500指数再创盘中纪录新高。美东时间11:34，道琼斯工业平均指数  上涨1.02%，报41,927.77点。标普500指数  上涨1.66%，报5711.6点；纳斯达克综合指数  上涨2.66%，报18040.538点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXD","DRI","TQQQ","SQQQ","3NVD.UK","COUR","DHI","FDS","LEN","IEF","ANGL","EWTX","FITB","LU","CRK","TOL","ELAN","KBH","TNDM","UDOW","VST","PHM","NQmain","VNDA","AHR","2NVD.UK","DASH","MBLY","DJX","SPOT","DOG","TGT","BANC",".DJI","KEY",".IXIC","HESM","CRMT"],"gpt_icon":1},{"id":"2468506319","title":"BUZZ-Edgewise Therapeutics 因心脏病药物的早期数据而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2468506319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468506319?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:59","pubTimestamp":1726757964,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月19日 - ** 药物开发商Edgewise Therapeutics   股价飙升45%，创下27.66美元的逾3年新高  ** 该公司称其治疗心脏病的实验性药物在一项早期研究中耐受性良好 ** EDG-7500 是一种用于治疗阻塞性肥厚型心肌病的药物，这种疾病会导致心肌增厚，增加心脏泵血的难度。 ** Truist Securities 分析师认为：\"早期数据表明，该药物正在发挥预期作用。 ** Truist将EWTX的PT值从25美元上调至33美元，较上一交易日收盘价上涨73%。** 包括盘中涨幅在内，该股今年累计涨幅超过一倍","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2468076572","title":"Edgewise Therapeutics, Inc.盘中异动 早盘大幅上涨35.03%报25.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468076572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468076572?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:30","pubTimestamp":1726752605,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时30分，Edgewise Therapeutics, Inc.股票出现异动，股价快速上涨35.03%。截至发稿，该股报25.75美元/股，成交量184.455万股，换手率1.97%，振幅0.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Edgewise Therapeutics, Inc.、Seres Therapeutics, Inc.、Candel Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为991.18%、299.68%、66.56%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213006a1db30ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213006a1db30ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2461188796","title":"Edgewise Therapeutics, Inc.盘中异动 大幅拉升5.13%报19.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461188796","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461188796?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:39","pubTimestamp":1724175546,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时39分，Edgewise Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Cingulate Inc.较为活跃，换手率分别为3522.94%、2468.06%、799.17%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Biomotion Sciences C/Wts Exp 15/08/2029 ，振幅分别为274.86%、128.68%、78.89%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082101390698e35938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082101390698e35938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","EWTX","LENZ","BK4539"],"gpt_icon":0},{"id":"1183248636","title":"异动解读 | Edgewise Therapeutics盘中大涨7.45% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1183248636","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183248636?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:30","pubTimestamp":1723739425,"startTime":"0","endTime":"0","summary":"北京时间2024年8月15日,生物制药公司Edgewise Therapeutics, Inc.股价在盘中出现大涨,最高上涨7.45%,报收17.95美元/股。公开消息显示,EWTX股价在当日盘中一度急速拉升5.28%,引发市场关注。分析人士认为,这可能与机构对该公司前景看好有关。Edgewise Therapeutics是一家临床阶段的生物制药公司,专注于开发治疗严重罕见肌肉疾病的创新疗法。公司正在研发口服小分子药物治疗肌肉骨骼疾病,在这一领域具有较强的竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX"],"gpt_icon":0},{"id":"2459223477","title":"Edgewise Therapeutics, Inc.2024财年第二财季实现净利润-31.50百万美元，同比减少46.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459223477","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459223477?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737809,"startTime":"0","endTime":"0","summary":"8月16日，Edgewise Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-31.50百万美元，同比减少46.72%；其中营业收入为0.00美元，每股基本收益为-0.34美元。从资产负债表来看，Edgewise Therapeutics, Inc.总负债21.17百万美元，其中短期债务988000.00美元，资产负债比为0.26，流动比率为0.31。机构评级：截至2024年8月16日，当前有6家机构对Edgewise Therapeutics, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为25.00美元，最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2459420495","title":"Edgewise Therapeutics, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420495?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728667,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，Edgewise Therapeutics, Inc.股票出现异动，股价急速拉升5.28%。截至发稿，该股报17.95美元/股，成交量9182股，换手率0.01%，振幅1.58%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2303.07%、1455.32%、333.77%，振幅较大的相关个股有Cingulate Inc.、Celcuity Inc.、Absci Corporation，振幅分别为28.18%、9.31%、9.11%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EWTX","LENZ","BK4539","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgewisetx.com","stockEarnings":[{"period":"1week","weight":-0.0663},{"period":"1month","weight":-0.1075},{"period":"3month","weight":0.1016},{"period":"6month","weight":0.5958},{"period":"1year","weight":1.4991},{"period":"ytd","weight":1.6271}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Edgewise Therapeutics, Inc.于2017年5月成立为特拉华州公司，总部位于科罗拉多州博尔德。 该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化针对严重，罕见的肌肉疾病的新疗法，这些药物对于医疗的需求尚未得到充分满足。公司的主要候选产品EDG-5506是一种口服小分子药物，旨在解决营养不良症的根本原因，包括杜氏肌营养不良（DMD）和贝克尔肌营养不良（BMD）。针对主要肌肉蛋白质和调节剂的精密药物候选产品的渠道，以解决广泛的遗传定义的肌肉疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.221382},{"month":2,"riseRate":0,"avgChangeRate":-0.093585},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.121355},{"month":4,"riseRate":0.25,"avgChangeRate":0.000577},{"month":5,"riseRate":0.5,"avgChangeRate":-0.024995},{"month":6,"riseRate":0.5,"avgChangeRate":-0.042597},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019509},{"month":8,"riseRate":0.5,"avgChangeRate":-0.023659},{"month":9,"riseRate":0.5,"avgChangeRate":0.091109},{"month":10,"riseRate":0.5,"avgChangeRate":0.083785},{"month":11,"riseRate":0.25,"avgChangeRate":-0.017527},{"month":12,"riseRate":0.25,"avgChangeRate":0.136572}],"exchange":"NASDAQ","name":"Edgewise Therapeutics, Inc.","nameEN":"Edgewise Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Edgewise Therapeutics, Inc.,EWTX,Edgewise Therapeutics, Inc.股票,Edgewise Therapeutics, Inc.股票老虎,Edgewise Therapeutics, Inc.股票老虎国际,Edgewise Therapeutics, Inc.行情,Edgewise Therapeutics, Inc.股票行情,Edgewise Therapeutics, Inc.股价,Edgewise Therapeutics, Inc.股市,Edgewise Therapeutics, Inc.股票价格,Edgewise Therapeutics, Inc.股票交易,Edgewise Therapeutics, Inc.股票购买,Edgewise Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况